[HTML] mdpi.com

[HTML][HTML] Neurotherapeutics for attention deficit/hyperactivity disorder (ADHD): a review

K Rubia, S Westwood, PM Aggensteiner, D Brandeis - Cells, 2021 - mdpi.com
This review focuses on the evidence for neurotherapeutics for attention deficit/hyperactivity
disorder (ADHD). EEG-neurofeedback has been tested for about 45 years, with the latest …
被引用次数：49 相关文章

Neurotherapeutics for Attention Deficit/Hyperactivity Disorder (ADHD): A Review.

K Rubia, S Westwood, PM Aggensteiner… - Cells (2073 …, 2021 - search.ebscohost.com
This review focuses on the evidence for neurotherapeutics for attention deficit/hyperactivity
disorder (ADHD). EEG-neurofeedback has been tested for about 45 years, with the latest …
[PDF] archive.org

[PDF][PDF] Neurotherapeutics for Attention Deficit Hyperactivity Disorder (ADHD): a Review

K Rubia, S Westwood, PM Aggensteiner, D Brandeis - 2021 - scholar.archive.org
Hyperactivity Disorder (ADHD). EEG-Neurofeedback has been tested for about 45 years
with latest meta-analyses of randomised controlled trials (RCT) showing small/medium …

Neurotherapeutics for Attention Deficit/Hyperactivity Disorder (ADHD): A Review

K Rubia, S Westwood, PM Aggensteiner, D Brandeis - Cells, 2021 - search.proquest.com
This review focuses on the evidence for neurotherapeutics for attention deficit/hyperactivity
disorder (ADHD). EEG-neurofeedback has been tested for about 45 years, with the latest …

Neurotherapeutics for Attention Deficit/Hyperactivity Disorder (ADHD): A Review

K Rubia, S Westwood, PM Aggensteiner, D Brandeis - Cells, 2021 - zora.uzh.ch
This review focuses on the evidence for neurotherapeutics for attention deficit/hyperactivity
disorder (ADHD). EEG-neurofeedback has been tested for about 45 years, with the latest …

Neurotherapeutics for Attention Deficit/Hyperactivity Disorder (ADHD): A Review

K Rubia, S Westwood, PM Aggensteiner, D Brandeis - 2021 - agris.fao.org
This review focuses on the evidence for neurotherapeutics for attention deficit/hyperactivity
disorder (ADHD). EEG-neurofeedback has been tested for about 45 years, with the latest …

Neurotherapeutics for Attention Deficit/Hyperactivity Disorder (ADHD): A Review

K Rubia, S Westwood, PM Aggensteiner… - Cells, 2021 - pubmed.ncbi.nlm.nih.gov
This review focuses on the evidence for neurotherapeutics for attention deficit/hyperactivity
disorder (ADHD). EEG-neurofeedback has been tested for about 45 years, with the latest …
[PDF] researchgate.net

[PDF][PDF] Neurotherapeutics for Attention Deficit Hyperactivity Disorder (ADHD): a Review

K Rubia, S Westwood, PM Aggensteiner, D Brandeis - 2021 - researchgate.net
Hyperactivity Disorder (ADHD). EEG-Neurofeedback has been tested for about 45 years
with latest meta-analyses of randomised controlled trials (RCT) showing small/medium …

Neurotherapeutics for Attention Deficit/Hyperactivity Disorder (ADHD): A Review.

K Rubia, S Westwood, PM Aggensteiner, D Brandeis - Cells, 2021 - europepmc.org
This review focuses on the evidence for neurotherapeutics for attention deficit/hyperactivity
disorder (ADHD). EEG-neurofeedback has been tested for about 45 years, with the latest …
[HTML] nih.gov

[HTML][HTML] Neurotherapeutics for Attention Deficit/Hyperactivity Disorder (ADHD): A Review

K Rubia, S Westwood, PM Aggensteiner, D Brandeis - Cells, 2021 - ncbi.nlm.nih.gov
This review focuses on the evidence for neurotherapeutics for attention deficit/hyperactivity
disorder (ADHD). EEG-neurofeedback has been tested for about 45 years, with the latest …